EffRx Pharmaceuticals SA, a commercial-stage pharmaceutical company focused on the development and commercialization of medications for musculoskeletal and rare diseases, announced that it has signed an exclusive licensing and distribution...
CureVac, in collaboration with GSK, recently announced the entry of its modified mRNA seasonal influenza vaccine candidate with multiple antigens into Phase II clinical trials. The preliminary results of Phase I trials demonstrated favorable...
BioNTech of Germany has announced a collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to further the development of its mpox vaccine. CEPI will provide funding of up to $90 million to support the development of vaccine...
Torrent Pharmaceuticals is in talks with private equity firms CVC Capital Partners and Bain Capital to raise cash for a stake in Cipla. The Indian pharmaceutical company intends to fund up to $1.5 billion in order to bid for Cipla...
The National Institutes of Health (NIH) in the United States announced the start of an early-stage research on an experimental vaccine targeting six strains of influenza virus. The vaccine candidate, FluMos-v2, is intended to protect against four...
vThe United States Food and Drug Administration (USFDA) has granted final approval to Zydus Lifesciences for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day (USRLD: Ortho Evra Transdermal System, 150 mcg/35 mcg per...
One of the most promising developments in the constantly developing field of medicine is pharmacologists.
Vial, a worldwide technology-driven CRO that provides next-generation clinical trial administration services, has joined forces with MLM Medical Labs ("MLM"), an international central and speciality laboratory with locations in Europe and North...
ICRA published its analysis of the local pharmaceutical market and predicted revenue increase of 8–10% for the fiscal year 2024. The Indian pharmaceutical industry (IPM) saw a solid compound annual growth rate (CAGR) of 9.7% between FY2014 and FY...
 - Copy.jpg)
The launch of AlveoGene, a new UK-based biotech created to develop medicines based on a lentiviral vector technology developed by researchers from the UK Respiratory Gene Therapy Consortium (GTC) to deliver gene therapies directly into the lungs...
, CDSCO.jpg)
